News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
PET-adapted BrECADD versus escBEACOPP in Hodgkin Lymphoma
Aug 1, 2024, 03:07

PET-adapted BrECADD versus escBEACOPP in Hodgkin Lymphoma

Graham Collins, Associate Professor, Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared a paper by Peter Borchmann et al. on X, adding:

“Front line treatment of Hodgkin Lymphoma with PET-adapted BrECADD versus escBEACOPP. BrECADD wins the day.

Can it be beaten…?”

Source: Graham Collins/X

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.

Authors: Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Sebastian Scholl, Max S Topp, Wolfram Jung, Vladan Vucinic, Hans-Joachim Beck, Andrea Kerkhoff, Benjamin Unger, Andreas Rank, Roland Schroers, Christian Meyer zum Büschenfelde, Maike de Wit, Karolin Trautmann-Grill, Peter Kamper, Daniel Molin, Stefanie Kreissl, Helen Kaul, Dipl-Math,  Bastian von Tresckow, Sven Borchmann, Karolin Behringer, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, L Hans-Theodor Eich, Christian Baues, Athanasios Zomas, Michael Hallek, Markus Dietlein, Carsten Kobe, and Volker Diehl.

BrECADD

Alden Moccia Alexander Fosså Andrea Kerkhoff Andreas Hüttmann Andreas Rank Andreas Rosenwald Andreas Viardot Andreas Zimmermann Athanasios Zomas Bastian von Tresckow Benjamin Unger Bernd Hertenstein BrECADD cancer Carsten Kobe Christian Baues Christian Meyer zum Büschenfelde Daniel Molin Dipl-Math escBEACOPP Felix Keil Graham Collins Gundolf Schneider Hans-Joachim Beck Helen Kaul Hodgkin lymphoma Josée M Zijlstra Judith Dierlamm Julia Meissner Justin Ferdinandus Karolin Behringer Karolin Trautmann-Grill L Hans-Theodor Eich Maike de Wit Mark Hertzberg Markus Dietlein Mathias Hänel Max S Topp Michael Fuchs Michael Hallek OncoDaily Oncology Peter Borchmann Peter Kamper Pratyush Giri Richard Greil Roland Schroers Sebastian Scholl Sonja Martin Stefanie Kreissl Stephan Mathas Sven Borchmann Urban Novak Valdete Schaub Vladan Vucinic Volker Diehl Wolfram Jung Wolfram Klapper
Special Coverage
Blog
Jan 15, 2025, 14:30
Dana Narvaez: Honored to be one of the selected young oncologists to receive the ASCO Idea Award 2025
Blog
Jan 15, 2025, 14:29
Findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024 - Cancer Network
Blog
Jan 15, 2025, 14:27
January is cervical cancer awareness month - National Cancer Institute of Kenya
Blog
Jan 15, 2025, 14:24
Yvonne Diaz on the hopes and concerns of cancer patients regarding the use of AI wearables - Lung Cancer Europe
Science
Jan 15, 2025, 14:23
A Perspective on the MARS2 Trial, by Eric Lim
Blog
Jan 15, 2025, 14:22
Anirban Maitra: The Revolution Medicines siblings
Blog
Jan 15, 2025, 14:19
Naoto T Ueno: The best multidisciplinary annual workshop in Asia
Blog
Jan 15, 2025, 14:17
Peter Pisters: Prevention is a cornerstone to End Cancer
Blog
Jan 15, 2025, 14:15
Finding Resiliency: Peace on the lung cancer path - LUNGevity Foundation
Blog
Jan 15, 2025, 14:14
A people-centered approach to cancer care - Union for International Cancer Control
Blog
Jan 15, 2025, 14:12
Justin Stebbing: Why a daily glass of milk really could reduce bowel cancer risk
Blog
Jan 15, 2025, 14:10
Carmen Uscatu: Is your goal simply to be heard?